- Advertisement -

Frailty: An important predictor of worse outcome after traumatic spinal cord injury

A new study has shown that frailty is an important predictor of worse outcome after traumatic spinal cord injury in patients less than 75...

Novartis, Artios Pharma Target Cancer in Up-to-$1.3B DDR Collaboration

Artios Pharma CEO Niall Martin, PhD Novartis has agreed to identify and validate next-generation DNA Damage Response (DDR) targets for precision cancer treatments using Artios...

Carefully engineered spike protein can help develop COVID-19 vaccine

The experimental vaccine against SARS-CoV-2 that was the first to enter human trials in the United States has been shown to elicit neutralizing antibodies...

Why grow GMOs? A farmer explains 4 environmental benefits of crop...

Unfortunately, biotechnology has taken quite a beating in public perception. We’ve seen activists’ smear campaigns disseminating misinformation. The most ridiculous claim is that farmers...

How micro(nano)plastics interact with human gut microbiota

In a recent study published in the Microbial Biotechnology journal, researchers explored the health effects of micro(nano)plastics and their degraded products on the gut...

Biotechnology can be a useful instrument for Europe’s recovery – The...

During Biotech Week, we celebrate the biotechnology sector, its fast-paced innovations and the hardworking people who create them. Life sciences and biotechnology are widely...

StockWatch: Revolution Shares Stay Flat Despite Historic FDA Approval of Oral...

Revolution Medicines (Nasdaq: RVMD) appeared to have the makings of another strong stock surge this past week when the FDA approved the company’s historic...

From Images to Data

Read NowQuantitative spatial biology is coming of age. The desire to learn beyond the surface has always been present but now the ability to...

StockWatch: Revolution Shares Stay Flat Despite Historic FDA Approval of Oral Pancreatic Cancer Therapy

Revolution Medicines (Nasdaq: RVMD) appeared to have the makings of another strong stock surge this past week when the FDA approved the company’s historic...

From Images to Data

Read NowQuantitative spatial biology is coming of age. The desire to learn beyond the surface has always been present but now the ability to...

Aprea Expands Development of WEE1 Inhibitor After Seeing Early Clinical Activity Signs vs. Cancer

Aprea Therapeutics is accelerating enrollment in its ongoing Phase I trial of its targeted cancer therapy APR-1051, one of the precision oncology drug developer’s...

more new items

StockWatch: Revolution Shares Stay Flat Despite Historic FDA Approval of Oral...

Revolution Medicines (Nasdaq: RVMD) appeared to have the makings of another strong stock surge this past week when the FDA approved the company’s historic...

From Images to Data

Read NowQuantitative spatial biology is coming of age. The desire to learn beyond the surface has always been present but now the ability to...

Aprea Expands Development of WEE1 Inhibitor After Seeing Early Clinical Activity...

Aprea Therapeutics is accelerating enrollment in its ongoing Phase I trial of its targeted cancer therapy APR-1051, one of the precision oncology drug developer’s...